IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Marinus Pharmaceuticals Inc

CUSIP: 56854Q101 | 240 institutional holders

Quarters

Q4 2020Q3 2020Q2 2020Q1 2020Q4 2019
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q4 2020

Bain Capital Life Sciences Investors, LLC1,431,058
0.0% of portfolio›$17.5K
Palo Alto Investors LP31,330
0.0% of portfolio›$382
StyleTurnoverLocationFiled
Bain Capital Life Sciences Investors, LLC
1,431,058$17.5K0.0%GARPMediumBoston, MA2021-02-16
Palo Alto Investors LP
31,330$3820.0%CoreMediumPalo Alto, CA2021-02-16